Literature DB >> 24033868

Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group.

Yasuo Sekine1, Takehiko Fujisawa, Kiminori Suzuki, Shuko Tsutatani, Kazuko Kubota, Hiroshi Ikegami, Yuji Isobe, Mitsugu Nakamura, Yuichi Takiguchi, Koichiro Tatsumi.   

Abstract

BACKGROUND AND
OBJECTIVE: Detection of chronic obstructive pulmonary disease (COPD) is crucial in the management of COPD. The aim of this study was to establish the utility of a community-based lung cancer screening for detecting COPD.
METHODS: In Japan, community-based lung cancer screening for residents who are 40 years or older using chest radiography is well established. A screening system in Chiba City, Japan, was used to detect COPD. The criteria to consider COPD at screening included age of 60 years or older, a smoking history and chronic respiratory symptoms. Participants fulfilling these criteria were referred for diagnostic evaluation consisting of pulmonary function testing (PFT) and chest computed tomography (CT).
RESULTS: Of 89,100 Chiba City residents who underwent lung cancer screening, 72,653 residents were 60 years or older. Among them, 878 (1.0%) were identified with suspected COPD and referred for further evaluation. Of those identified, a total of 567 residents (64.6%, 567/878) underwent further evaluations, and 161 (28.4%) were reported to have COPD, with 38.5% of them requiring COPD treatment. To verify the diagnoses from the secondary evaluation centres, PFT and CT data were collected from 228 study participants, and 24.9% were diagnosed with COPD. CT findings classified according to the Goddard classification revealed that 20.1% of these participants had moderate to severe emphysema.
CONCLUSIONS: COPD screening added to a community-based lung cancer screening programme may be effective in the detection of patients with COPD.
© 2013 The Authors. Respirology © 2013 Asian Pacific Society of Respirology.

Entities:  

Keywords:  chronic obstructive pulmonary disease; computed tomography; lung cancer; pulmonary function testing; screening

Mesh:

Year:  2014        PMID: 24033868     DOI: 10.1111/resp.12179

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  8 in total

1.  Late-Onset Asthma: A Diagnostic and Management Challenge.

Authors:  Charlotte Suppli Ulrik
Journal:  Drugs Aging       Date:  2017-03       Impact factor: 3.923

Review 2.  Lung carcinogenesis from chronic obstructive pulmonary disease: characteristics of lung cancer from COPD and contribution of signal transducers and lung stem cells in the inflammatory microenvironment.

Authors:  Yasuo Sekine; Atsushi Hata; Eitetsu Koh; Kenzo Hiroshima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-03-14

Review 3.  Chronic obstructive pulmonary disease as a risk factor for lung cancer.

Authors:  Yuichi Takiguchi; Ikuo Sekine; Shunichiro Iwasawa; Ryota Kurimoto; Koichiro Tatsumi
Journal:  World J Clin Oncol       Date:  2014-10-10

4.  The regional association between bronchiectasis and lung cancer in chest CT.

Authors:  Yeon Wook Kim; Chang-Hoon Lee; Kwang-Nam Jin; Jung-Kyu Lee; Eun Young Heo; Sung Soo Park; Hee Soon Chung; Deog Kyeom Kim
Journal:  BMC Pulm Med       Date:  2016-11-15       Impact factor: 3.317

5.  PD-L1, FGFR1, PIK3CA, PTEN, and p16 expression in pulmonary emphysema and chronic obstructive pulmonary disease with resected lung squamous cell carcinoma.

Authors:  Ken Arimura; Yasuo Sekine; Kenzo Hiroshima; Satoru Shimizu; Noriyuki Shibata; Mitsuko Kondo; Kiyoshi Takeyama; Etsuko Tagaya
Journal:  BMC Pulm Med       Date:  2019-09-03       Impact factor: 3.317

6.  Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.

Authors:  Stephen G Spiro; Pallav L Shah; Robert C Rintoul; Jeremy George; Samuel Janes; Matthew Callister; Marco Novelli; Penny Shaw; Gabrijela Kocjan; Chris Griffiths; Mary Falzon; Richard Booton; Nicholas Magee; Michael Peake; Paul Dhillon; Kishore Sridharan; Andrew G Nicholson; Simon Padley; Magali N Taylor; Asia Ahmed; Jack Allen; Yenting Ngai; Nyasha Chinyanganya; Victoria Ashford-Turner; Sarah Lewis; Dahmane Oukrif; Pamela Rabbitts; Nicholas Counsell; Allan Hackshaw
Journal:  Eur Respir J       Date:  2019-10-17       Impact factor: 16.671

7.  Feasibility and acceptability of a community pharmacy referral service for suspected lung cancer symptoms.

Authors:  Daniella Holland-Hart; Grace M McCutchan; Harriet Dorothy Quinn-Scoggins; Kate Brain; Lucy Hill; Savita Shanbag; Michael Abel; Kelly White; Angela Evans; Sarah Rees; Sarah Bowen; Rachel Gemine; Gareth Collier
Journal:  BMJ Open Respir Res       Date:  2021-08

8.  Surveillance of chronic obstructive pulmonary disease in high-risk individuals by using regional lung cancer mass screening.

Authors:  Yasuo Sekine; Ryoko Yanagibori; Kiminori Suzuki; Sonomi Sugiyama; Haruko Yamaji; Michiko Ishibashi; Takehiko Fujisawa
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.